NGM·Healthcare·$210M·#181 / 520 in Healthcare
RXST RxSight, Inc.
55SPECULATIVE
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY68
VALUATION97
GOVERNANCE62
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-3.9%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
76.6%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
15 months
54
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
4.0%
97
< 25% strong
Price / Sales
Market cap relative to trailing revenue
1.6x
97
< 3x strong
Rule of 40
Growth rate plus operating margin
-40
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
6.4%
47
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+1.2%
93
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE RXST WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when RXST's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.